Showing results (591-600 of 607) with videos related to

Sort By:
Pageof 61
JAMA Oncology|February 20, 2025
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical TrialCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancerCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Psychological Medicine|April 18, 2015
Predictors of treatment dropout in self-guided web-based interventions for depression: an 'individual patient data' meta-analysisE Karyotaki, A Kleiboer, F Smit, et al.
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Kidney International|July 15, 2019
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammationDaniela Egli-Spichtig, Pedro Henrique Imenez Silva, Bob Glaudemans, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoidsBiao Huang, Zipeng Zeng, Hui Li, et al.
Communications Biology|January 13, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediateGiovanni Spagnolli, Tania Massignan, Andrea Astolfi, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 20, 2008
[Preliminary results of the Spanish Society of Nephrology multicenter study of quality performance measures: hemodialysis outcomes can be improved]J M Alcázar, M D Arenas, F Alvarez-Ude, et al.
Journal of Medicinal Chemistry|February 28, 2016
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based DesignMatthew Volgraf, Benjamin D Sellers, Yu Jiang, et al.
Science Translational Medicine|August 31, 2018
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeabilityAndrew J King, Matthew Siegel, Ying He, et al.
Pageof 61